Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-14 | Amended | $4,188,529 | $3,188,529 | Equity Only | 06b | SEC link |
| 2024-07-18 | New | $1,000,000 | $1,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Brett Janis | Director, Executive |
| Jonathan Kopecheck | Director, Executive |
| Michael Menze | Director, Executive |
| Robert Saunders | Director |